Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-20-001866
Filing Date
2020-03-02
Accepted
2020-03-02 16:03:08
Documents
2
Period of Report
2020-02-27

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 4105
2 THOMAS BURES - POWER OF ATTORNEY bures-16poa.txt EX-24 3489
  Complete submission text file 0001562180-20-001866.txt   9105
Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Issuer) CIK: 0001583648 (see all company filings)

EIN.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address C/O PIERIS PHARMACEUTICALS, INC. 255 STATE STREET, 9TH FLOOR BOSTON MA 02109
Business Address
Bures Thomas (Reporting) CIK: 0001787029 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37471 | Film No.: 20676751